Evidence map›Paper›PMID 38380590›Full record

Observational studyFuture oncology (London, England)2024

Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA.

Charles Dharmani, Oluwatosin Fofah, Eric Wang, Maribel Salas, Margaret Wooddell, Nora Tu, Jenny Tse, Aimee Near, Gabriel Tinoco

Abstract readObservational Study
In one paragraph

Observational study in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Charles DharmaniDaiichi Sankyo, Inc., 211, Mt. Airy Road, Basking Ridge, NJ 07920, USA.ORCID 0000-0003-3641-9738
Oluwatosin FofahRutgers University, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA.ORCID 0000-0003-2470-8276
Eric WangDaiichi Sankyo, Inc., 211, Mt. Airy Road, Basking Ridge, NJ 07920, USA.ORCID 0000-0002-9937-9959
Maribel SalasDaiichi Sankyo, Inc., 211, Mt. Airy Road, Basking Ridge, NJ 07920, USA.ORCID 0000-0001-5634-1558
Margaret WooddellDaiichi Sankyo, Inc., 211, Mt. Airy Road, Basking Ridge, NJ 07920, USA.
Nora TuDaiichi Sankyo, Inc., 211, Mt. Airy Road, Basking Ridge, NJ 07920, USA.ORCID 0000-0001-9034-199X
Jenny TseIQVIA, Durham, NC 27703, USA.ORCID 0000-0002-0035-2079
Aimee NearIQVIA, Durham, NC 27703, USA.ORCID 0000-0001-9423-8244
Gabriel TinocoThe Ohio State University Wexner Medical Center, 460 W 10th Ave, Columbus, OH 43210, USA.ORCID 0000-0002-2565-6124

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Giant Cell Tumor of Tendon SheathAdultAgedAminopyridinesAntineoplastic AgentsDrug UtilizationFemaleHumansMaleMiddle AgedPyrrolesRetrospective StudiesUnited StatesAminopyridinesAntineoplastic AgentspexidartinibPyrrolesdose reductiondrug utilizationepidemiologypexidartinibpigmented villonodular synovitisPVNSsystemic therapiestenosynovial giant cell tumorTGCTtreatment durationtreatment patternsunmet need

Identifiers

PMID38380590
PMCPMC11721949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.